Tenet Healthcare Corporation

NYSE:THC Rapporto sulle azioni

Cap. di mercato: US$15.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Tenet Healthcare Crescita futura

Future criteri di controllo 0/6

Si prevede che gli utili di Tenet Healthcare diminuiranno a 32% all'anno, mentre si prevede che i suoi ricavi annuali cresceranno a 3.7% all'anno. Si prevede che l'EPS diminuirà di 32.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà 12.8% in 3 anni.

Informazioni chiave

-32.0%

Tasso di crescita degli utili

-32.7%

Tasso di crescita dell'EPS

Healthcare crescita degli utili19.3%
Tasso di crescita dei ricavi3.7%
Rendimento futuro del capitale proprio12.8%
Copertura analitica

Good

Ultimo aggiornamento22 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Aug 13
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21
With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30
Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Jan 31
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Compressed Multiples Appear Justified

Jan 27

Tenet Health gains on on report David Einhorn's Greenlight has stake

Jan 17

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Jan 13
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Tenet Healthcare: Earnings Headwinds With Mixed Technicals

Nov 11

Previsioni di crescita degli utili e dei ricavi

NYSE:THC - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202622,7651,0941,9192,53215
12/31/202521,7401,0091,9402,37618
12/31/202420,8502,8962,6791,96817
6/30/202420,9102,7551,8912,660N/A
3/31/202420,8952,6191,7552,511N/A
12/31/202320,5486111,6232,374N/A
9/30/202320,1704691,1381,971N/A
6/30/202319,9054999611,783N/A
3/31/202319,4534144621,304N/A
12/31/202219,1744103211,083N/A
9/30/202219,0405582431,019N/A
6/30/202219,1338754141,136N/A
3/31/202219,4499575701,262N/A
12/31/202119,4859159101,568N/A
9/30/202119,5441,0791,1371,657N/A
6/30/202119,2074341,3231,818N/A
3/31/202117,9014023,3333,812N/A
12/31/202017,6403992,8673,407N/A
9/30/202017,531-182,9293,481N/A
6/30/202017,542-482,6853,307N/A
3/31/202018,454-1126921,352N/A
12/31/201918,479-2265631,233N/A
9/30/201918,292-228258963N/A
6/30/201918,213-10197882N/A
3/31/201918,159-10280946N/A
12/31/201818,3131014321,049N/A
9/30/201818,672-1176711,290N/A
6/30/201818,769-4746331,260N/A
3/31/201819,065-554N/A1,127N/A
12/31/201719,179-704N/A1,200N/A
9/30/201719,061-553N/A416N/A
6/30/201719,324-196N/A377N/A
3/31/201719,390-184N/A597N/A
12/31/201619,621-187N/A558N/A
9/30/201619,787-208N/A1,042N/A
6/30/201619,630-227N/A1,255N/A
3/31/201619,254-243N/A1,230N/A
12/31/201518,634-142N/A1,026N/A
9/30/201518,07319N/A1,054N/A
6/30/201517,55657N/A793N/A
3/31/201517,101107N/A649N/A
12/31/201416,60334N/A687N/A
9/30/201416,023-44N/A723N/A
6/30/201414,256-21N/A708N/A
3/31/201412,641-64N/A602N/A
12/31/201311,087-123N/A589N/A
9/30/20139,548-50N/A590N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che gli utili di THC diminuiranno nei prossimi 3 anni ( -32% all'anno).

Guadagni vs Mercato: Si prevede che gli utili di THC diminuiranno nei prossimi 3 anni ( -32% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di THC diminuiranno nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di THC ( 3.7% all'anno) crescerà più lentamente rispetto al mercato US ( 8.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di THC ( 3.7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di THC sarà basso tra 3 anni ( 12.8 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y